fda approves new bladder cancer drug | dr. daniel petrylak
Published 4 years ago • 463 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
1:06
dr. daniel petrylak on early trials for a new urothelial bladder cancer treatment
-
0:57
dr. petrylak on immunotherapy in bladder cancer
-
1:01
dr. petrylak on novel immunotherapy research in bladder cancer
-
51:09
fapi theranostics for prostate cancer
-
56:45
lab talk: fgfr3 testing in bladder cancer by dr. michael hubank
-
6:47
immunotherapy and the side effects
-
0:51
daniel p. petrylak, md, regarding pd-l1 biomarkers in the treatment of bladder cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
0:56
dr. petrylak on ongoing investigations of checkpoint inhibition in bladder cancer
-
1:06
dr. petrylak discusses bcg for the treatment of patients with non-invasive bladder cancer
-
0:58
daniel p. petrylak, md, on immunotherapy & chemotherapy combinations in metastatic bladder cancer
-
1:51
petrylak ramucirumab sept2017 1080
-
0:47
daniel p. petrylak, md, on molecular characterization & bladder subtyping in bladder cancer
-
1:11
dr. petrylak on sequencing agents in prostate cancer
-
49:55
yale cancer center grand rounds | june 8, 2021
-
0:56
meet oncologist daniel petrylak, md
-
1:05
dr. petrylak on combinations with pembrolizumab in urothelial carcinoma
-
0:31
daniel petrylak, md, expresses the efficacy of infigratinib in fgfr3-altered muc patients
-
0:34
dr. petrylak discusses custirsen as a potential treatment for prostate cancer
-
8:12
asco gu 2020: dr. petrylak discusses exciting prostate cancer and bladder cancer data